This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ally, S. Articles by Cho-Chung, Y. S. Search for Related Content PubMed PubMed Citation Articles by Ally, S. Articles by Cho-Chung, Y. S.

Inhibition of Growth and Modulation of Gene Expression in Human Lung Carcinoma in Athymic Mice by Site-selective 8-Cl-Cyclic Adenosine Monophosphate

Cellular Biochemistry Section, Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 [S. A., T. C., D. K., G. T., H. Y., Y. S. C-C.], and Nucleic Acid Research Institute, Costa Mesa, California 92626 [R. A. F., T. L. A.]

Site-selective cyclic AMP (cAMP) analogues inhibit growth and induce changes in morphology in a spectrum of human cancer cell lines (D. Katsaros et al., FEBS Lett., 223:97, 1987). The cellular events underlying such effects of cAMP analogues include differential regulation of type I versus type II cAMP-dependent protein kinase isozymes (S. Ally et al., Proc. Natl. Acad. Sci. USA, 85: 6319, 1988). Infusion (i.p.) of 8-Cl-cAMP, the most potent site-selective cAMP analogue, for 7 days produced regression of LX-1 lung carcinoma in athymic mice in a dose-dependent manner. The tumor regression correlated with the changing levels of cAMP receptor proteins, RI and RII_ß, the regulatory subunits of cAMP-dependent protein kinase type I and type II, respectively. By photoaffinity labeling with 8-N₃-[³²P]cAMP and immunoblotting with a monospecific anti-RII antibody, RI (M_r 49,000) and RII_ß (M_r 51,000) were identified in the untreated control tumors. 8-Cl-cAMP treatment induced a rapid increase of both RI and RII_ß in tumor cytosols and translocation (within 1 h) of only RII_ß from the cytosol to the nucleus. RII_ß in both cytosols and nuclei remained elevated during 8-Cl-cAMP treatment, whereas RI in the cytosols gradually decreased with time of treatment after its initial transient increase. Northern blot analyses demonstrated that the RII_ß mRNA level increased within 6 h of 8-Cl-cAMP treatment and remained elevated during treatment, whereas the RI mRNA level decreased to below that of the untreated control tumor level after its transient increase during 1–6 h of treatment. 8-Cl-cAMP treatment also caused a sharp decrease in both N-ras and c-myc mRNA levels. These results suggest that the fundamental basis for the antineoplastic activity of 8-Cl-cAMP may reside in the restoration of normal gene regulation in neoplasms in which cAMP receptor proteins play a role.

¹ To whom requests for reprints should be addressed, at Cellular Biochemistry Section, Laboratory of Tumor Immunology and Biology, National Cancer Institute, NIH, Building 10, Room 5B38, Bethesda, MD 20892.

Received 2/27/89. Revised 5/22/89. Accepted 7/20/89.

This article has been cited by other articles:

				K. Balakrishnan, C. M. Stellrecht, D. Genini, M. Ayres, W. G. Wierda, M. J. Keating, L. M. Leoni, and V. Gandhi Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP Blood, June 1, 2005; 105(11): 4455 - 4462. [Abstract] [Full Text] [PDF]

				K. Balmanno, T. Millar, M. McMahon, and S. J. Cook {Delta}Raf-1:ER* Bypasses the Cyclic AMP Block of Extracellular Signal-Regulated Kinase 1 and 2 Activation but Not CDK2 Activation or Cell Cycle Reentry Mol. Cell. Biol., December 15, 2003; 23(24): 9303 - 9317. [Abstract] [Full Text] [PDF]

				C. M. Stellrecht, C. O. Rodriguez Jr., M. Ayres, and V. Gandhi RNA-Directed Actions of 8-Chloro-Adenosine in Multiple Myeloma Cells Cancer Res., November 15, 2003; 63(22): 7968 - 7974. [Abstract] [Full Text] [PDF]

				N. Dumaz, Y. Light, and R. Marais Cyclic AMP Blocks Cell Growth through Raf-1-Dependent and Raf-1-Independent Mechanisms Mol. Cell. Biol., June 1, 2002; 22(11): 3717 - 3728. [Abstract] [Full Text] [PDF]

				V. Gandhi, M. Ayres, R. G. Halgren, N. L. Krett, R. A. Newman, and S. T. Rosen 8-Chloro-cAMP and 8-Chloro-adenosine Act by the Same Mechanism in Multiple Myeloma Cells Cancer Res., July 1, 2001; 61(14): 5474 - 5479. [Abstract] [Full Text] [PDF]

				C. Indolfi, E. Di Lorenzo, A. Rapacciuolo, A. M. Stingone, E. Stabile, A. Leccia, D. Torella, R. Caputo, F. Ciardiello, G. Tortora, et al. 8-Chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo J. Am. Coll. Cardiol., July 1, 2000; 36(1): 288 - 293. [Abstract] [Full Text] [PDF]

				H. X. Chen, J. L. Marshall, E. Ness, R. R. Martin, B. Dvorchik, N. Rizvi, J. Marquis, M. McKinlay, W. Dahut, and M. J. Hawkins A Safety and Pharmacokinetic Study of a Mixed-Backbone Oligonucleotide (GEM231) Targeting the Type I Protein Kinase A by Two-hour Infusions in Patients with Refractory Solid Tumors Clin. Cancer Res., April 1, 2000; 6(4): 1259 - 1266. [Abstract] [Full Text]

				D. J. Propper, M. P. Saunders, A. J. Salisbury, L. Long, K. J. O'Byrne, J. P. Braybrooke, M. Dowsett, M. Taylor, D. C. Talbot, T. S. Ganesan, et al. Phase I Study of the Novel Cyclic AMP (cAMP) Analogue 8-Chloro-cAMP in Patients with Cancer: Toxicity, Hormonal, and Immunological Effects Clin. Cancer Res., July 1, 1999; 5(7): 1682 - 1689. [Abstract] [Full Text] [PDF]

				M. C. MacNicol and A. M. MacNicol Nerve Growth Factor-stimulated B-Raf Catalytic Activity Is Refractory to Inhibition by cAMP-dependent Protein Kinase J. Biol. Chem., May 7, 1999; 274(19): 13193 - 13197. [Abstract] [Full Text] [PDF]

				M. P. Saunders, A. J. Salisbury, K. J. O'Byrne, L. Long, R. M. Whitehouse, D. C. Talbot, E. B. Mawer, and A. L. Harris A Novel Cyclic Adenosine Monophosphate Analog Induces Hypercalcemia via Production of 1,25-Dihydroxyvitamin D in Patients with Solid Tumors J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4044 - 4048. [Abstract] [Full Text] [PDF]

				G. Tortora, R. Caputo, V. Damiano, R. Bianco, S. Pepe, A. R. Bianco, Z. Jiang, S. Agrawal, and F. Ciardiello Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A PNAS, November 11, 1997; 94(23): 12586 - 12591. [Abstract] [Full Text] [PDF]